Last10K.com

Respirerx Pharmaceuticals Inc. (RSPI) SEC Filing 8-K Material Event for the period ending Monday, September 24, 2018

Respirerx Pharmaceuticals Inc.

CIK: 849636 Ticker: RSPI

View differences made from one to another to evaluate Respirerx Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Respirerx Pharmaceuticals Inc..

Continue

Assess how Respirerx Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Respirerx Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools
Ticker: RSPI
CIK: 849636
Form Type: 8-K Corporate News
Accession Number: 0001493152-18-013860
Submitted to the SEC: Fri Sep 28 2018 11:33:37 AM EST
Accepted by the SEC: Fri Sep 28 2018
Period: Monday, September 24, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rspi/0001493152-18-013860.htm